Peer Review History

Original SubmissionFebruary 14, 2025
Decision Letter - Atakan Orscelik, Editor

Dear Dr. Kim,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Atakan Orscelik

Academic Editor

PLOS ONE

Journal requirements: 

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf .

2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

3. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: This study investigates the association between the proximal and distal middle cerebral artery (MCA) diameter ratio and different pathomechanisms of lenticulostriate artery (LSA) infarction, specifically lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The authors retrospectively analyzed 117 patients with acute LSA infarctions, differentiating LD and BAD based on infarct size and axial slice involvement. The study employed computational fluid dynamics (CFD) analysis to assess hemodynamic parameters and identified a significant correlation between a higher proximal/distal M1 diameter ratio and LD. Here are my comments;

1- The differentiation between LD and BAD relies on infarct size and slice-based criteria, which may not always provide a definitive classification. Since vessel wall imaging or perfusion studies could improve diagnostic precision, it would be helpful for the authors to acknowledge these limitations and discuss the potential for misclassification in their findings.

2-The CFD analysis provides valuable insights, but its assumptions oversimplify real-world hemodynamics. The use of steady-state modeling and rigid arterial walls does not fully capture the dynamic nature of cerebral blood flow. Addressing how these limitations might affect the results and considering alternative modeling approaches would improve the robustness of the conclusions.

3-The single-center study design with a relatively small sample size raises concerns about generalizability. Given the potential variations in cerebrovascular anatomy across populations, a larger multicenter validation would be necessary to confirm the findings. The authors should discuss this limitation and its implications for broader clinical application.

The manuscript presents a novel perspective on MCA geometry and LSA infarction but requires significant revision for clarity, methodological rigor, and validation.

Reviewer #2: This manuscript presents an original and methodologically sound investigation into the relationship between the proximal-to-distal diameter ratio of the middle cerebral artery (M1 segment) and the underlying mechanism of lenticulostriate artery (LSA) infarction, particularly in distinguishing between lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The study brings together vascular geometry, neuroimaging, and computational fluid dynamics (CFD) modeling in a well-integrated, multidisciplinary approach that offers meaningful insights.

The manuscript is clearly structured, and the narrative flows well. The data analysis appears appropriate, and the conclusions are thoughtfully derived from the presented results. By exploring anatomical and hemodynamic determinants of stroke subtypes, the study adds a meaningful contribution to the field.

To enhance clarity and reproducibility, the following points are offered for consideration:

1. Methodological and Interpretive Considerations

- Variability in M1 diameter measurements on MRA may arise due to inter- and intra-observer differences. Including a brief explanation of how measurement reliability was ensured would help strengthen the methodological transparency.

- Conventional MRA techniques, such as time-of-flight (TOF) MRA, may have limited sensitivity in detecting plaques that cause only mild luminal narrowing (e.g., <50%). It might be helpful to briefly mention this limitation in the manuscript. If vessel wall imaging was performed in any case, including those findings could add useful context.

- Since the CFD simulations were based on idealized rather than patient-specific geometries, a brief discussion regarding anatomical variability and related limitations could provide additional context.

- The inclusion of ROC analysis (e.g., AUC, sensitivity, specificity), along with a proposed cut-off value for the M1 diameter ratio, may help improve the clinical relevance of the findings.

2. Figure Presentation

- In Figure 1, some label texts seem to lack sufficient contrast with the background, which may reduce readability. Adjusting text color or weight could enhance visual clarity.

- Figure 2 appears to have relatively low resolution. A higher-quality version would likely improve overall image presentation.

- In Figure 3, several text labels look slightly distorted or unclear. Improving the sharpness and clarity of these labels may enhance the figure's effectiveness.

These comments are shared in a collaborative and respectful spirit, with appreciation for the authors’ thoughtful contribution.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes:  Yigit Can Senol

Reviewer #2: Yes:  Il Kwon

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

PONE-D-25-05856

Manuscript title: Proximal and distal middle cerebral artery diameter ratio and lenticulostriate artery infarction

Author list: Jun Sang Yoo, MD, Jae Hyun Choi, Jae Young Park, Jeong Yun Song, Jun Young Chang, Dong-Wha Kang, Sun U. Kwon, HangJin Jo, Bum Joon Kim

Response to reviewers' comments

Dear reviewers and editorial staffs in PLOS ONE

We would like to express our sincere gratitude for your thorough scrutiny of our manuscript. Since receiving the reviewer’s comments, we have made every effort to bring our manuscript to the scientific and literary level required by the PLOS ONE.

We hope the revised manuscript will be considered suitable for publication in your journal.

N.B. Texts written in bold with 11-point Arial fonts are verbatim of reviewers' comments. The authors' responses are given below each comment.

Reviewer #1: This study investigates the association between the proximal and distal middle cerebral artery (MCA) diameter ratio and different pathomechanisms of lenticulostriate artery (LSA) infarction, specifically lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The authors retrospectively analyzed 117 patients with acute LSA infarctions, differentiating LD and BAD based on infarct size and axial slice involvement. The study employed computational fluid dynamics (CFD) analysis to assess hemodynamic parameters and identified a significant correlation between a higher proximal/distal M1 diameter ratio and LD. Here are my comments;

1- The differentiation between LD and BAD relies on infarct size and slice-based criteria, which may not always provide a definitive classification. Since vessel wall imaging or perfusion studies could improve diagnostic precision, it would be helpful for the authors to acknowledge these limitations and discuss the potential for misclassification in their findings.

We acknowledge the limitation in our methodology for differentiating between LD and BAD based solely on infarct size and slice-based criteria. As the reviewer correctly points out, this approach may not always provide definitive classification, as there are other various ways to classify. But although high-resolution MRI or perfusion MRI can more accurately distinguish between LD and BAD, in real-world clinical practice TOF-MRA is used most frequently. Therefore, we sought the most practical diagnostic approach to define BAD using TOF-MRA. We have added the following paragraph to the Discussion section:

“Second major limitation in our study is the difficulty in definitively distinguishing between LD and BAD using conventional MRI TOF images. Advanced imaging techniques such as high-resolution vessel wall imaging could potentially provide more precise pathophysiological classification, by identifying culprit plaques or atheromas adjacent to perforator arteries. TOF-MRA has inherent limitations in detecting non-stenotic atherosclerotic plaques or those causing only mild luminal narrowing. Positive remodeling and early-stage atherosclerotic changes may be present without significant luminal narrowing, potentially leading to underestimation of atherosclerotic burden in both groups. In the absence of high-resolution modalities, we relied on established radiological criteria based on infarct size and axial slice involvement, which may have resulted in some degree of misclassification. However, TOF-MRA is currently the most widely used conventional tool in real-world clinical practice, and we believe that classification and analysis based on it will be of practical benefit. Future studies incorporating advanced vessel wall imaging techniques may help validate and refine our findings.”

2- The CFD analysis provides valuable insights, but its assumptions oversimplify real-world hemodynamics. The use of steady-state modeling and rigid arterial walls does not fully capture the dynamic nature of cerebral blood flow. Addressing how these limitations might affect the results and considering alternative modeling approaches would improve the robustness of the conclusions.

We agree that our CFD analysis employs several simplifications that do not fully capture the complexity of cerebral hemodynamics. In patients, the actual vascular geometry—particularly the distal ICA bifurcation—is often tortuous, generating turbulence that varies with individual vessel curvature. However, our CFD model assumes laminar flow and thus cannot accurately replicate true hemodynamic conditions. Furthermore, patient-specific factors such as endothelial function, pulsatility index parameters were generalized, and the number and size of perforators—too minute to measure—were all set to average values. Consequently, our CFD analysis remains a conceptual study. Nevertheless, because no prior research of this nature has been conducted in ischemic stroke, we anticipate that PLOS ONE readers will recognize how these hemodynamic factors could influence the pathophysiology of small vessel disease. We have expanded our limitations section to include:

"Our CFD simulations were based on idealized models using average measurements and simplified assumptions, such as steady-state flow and rigid arterial walls, which do not fully reflect the complex, dynamic nature of cerebral blood flow. These models did not incorporate individual anatomical variations, including the precise angle and number of perforators, variations in vessel diameter, or potential focal irregularities in the M1 segment. Furthermore, standardized parameters may overlook inter-individual differences in collateral flow patterns and cerebrovascular reactivity, both of which could significantly influence local hemodynamics. These limitations necessitate cautious interpretation of our findings and underscore the importance of future studies employing patient-specific CFD modeling with pulsatile flow, arterial wall elasticity, and high-resolution imaging to improve physiological accuracy and clinical relevance. In subsequent studies, we intend to employ 3D printing and particle image velocimetry.”

3- The single-center study design with a relatively small sample size raises concerns about generalizability. Given the potential variations in cerebrovascular anatomy across populations, a larger multicenter validation would be necessary to confirm the findings. The authors should discuss this limitation and its implications for broader clinical application.

We have acknowledged the limitations of our single-center design and relatively small sample size by adding:

"The single-center design and modest sample size (n=117) of our study limit the generalizability of our findings. Cerebrovascular anatomy and risk factor profiles can vary significantly across different populations and ethnicities. Our findings should be considered preliminary until validated in larger, multicenter cohorts representing diverse populations. Such validation would be essential before considering the proximal/distal M1 diameter ratio as a clinically applicable biomarker for differentiating between LD and BAD mechanisms."

We are grateful for your identification of the limitations we had overlooked. Nonetheless, despite these limitations, we maintain that the principal merit of our report lies in its pioneering demonstration of how vascular morphology and hemodynamic factors may influence the pathophysiology of small vessel disease.

Reviewer #2: This manuscript presents an original and methodologically sound investigation into the relationship between the proximal-to-distal diameter ratio of the middle cerebral artery (M1 segment) and the underlying mechanism of lenticulostriate artery (LSA) infarction, particularly in distinguishing between lipohyalinotic degeneration (LD) and branch atheromatous disease (BAD). The study brings together vascular geometry, neuroimaging, and computational fluid dynamics (CFD) modeling in a well-integrated, multidisciplinary approach that offers meaningful insights.

The manuscript is clearly structured, and the narrative flows well. The data analysis appears appropriate, and the conclusions are thoughtfully derived from the presented results. By exploring anatomical and hemodynamic determinants of stroke subtypes, the study adds a meaningful contribution to the field.

To enhance clarity and reproducibility, the following points are offered for consideration:

1. Methodological and Interpretive Considerations

- Variability in M1 diameter measurements on MRA may arise due to inter- and intra-observer differences. Including a brief explanation of how measurement reliability was ensured would help strengthen the methodological transparency.

- Conventional MRA techniques, such as time-of-flight (TOF) MRA, may have limited sensitivity in detecting plaques that cause only mild luminal narrowing (e.g., <50%). It might be helpful to briefly mention this limitation in the manuscript. If vessel wall imaging was performed in any case, including those findings could add useful context.

- Since the CFD simulations were based on idealized rather than patient-specific geometries, a brief discussion regarding anatomical variability and related limitations could provide additional context.

- The inclusion of ROC analysis (e.g., AUC, sensitivity, specificity), along with a proposed cut-off value for the M1 diameter ratio, may help improve the clinical relevance of the findings.

We sincerely appreciate Reviewer #2's positive assessment of our manuscript and the thoughtful suggestions provided. We have addressed each point to enhance the clarity and reproducibility of our study as follows:

1. Methodological and Interpretive Considerations

Measurement Reliability

We agree that addressing measurement reliability is important. We have added the following paragraph to the Methods section:

"To ensure measurement reliability, all MCA geometric measurements were performed independently by two trained neurologists (J.S.Y. and J.Y.P.) who were blinded to the clinical information and stroke subtype classification. For each parameter (proximal M1 diameter, distal M1 diameter, actual and straight length of M1), measurements were obtained twice, and the average value was used for analysis. Inter-observer reliability was assessed using intraclass correlation coefficients (ICCs), which showed excellent agreement for all measurements (proximal M1 diameter: ICC=0.92, 95% CI 0.88-0.95; distal M1 diameter: ICC=0.90, 95% CI 0.86-0.94; M1 length: ICC=0.89, 95% CI 0.84-0.93). In cases of substantial disagreement (>10% difference), a consensus was reached through joint review with a senior neuroradiologist (B.J.K.)."

MRA Technique Limitations

As the reviewer correctly points out, high-resolution MRI can more accurately detect plaques or stenosis of vessels. But in real-world clinical practice TOF-MRA is used most frequently. Therefore, we used the most practical diagnostic sequence, which is TOF-MRA. We have acknowledged the limitations of TOF-MRA in detecting mild stenosis by adding:

" Second major limitation in our study is the difficulty in definitively distinguishing between LD and BAD using conventional MRI TOF images. Advanced imaging techniques such as high-resolution vessel wall imaging could potentially provide more precise pathophysiological classification, by identifying culprit plaques or atheromas adjacent to perforator arteries. TOF-MRA has inherent limitations in detecting non-stenotic atherosclerotic plaques or those causing only mild luminal narrowing. Positive remodeling and early-stage atherosclerotic changes may be present without significant luminal narrowing, potentially leading to underestimation of atherosclerotic burden in both groups. In the absence of high-resolution modalities, we relied on established radiological criteria based on infarct size and axial slice involvement, which may have resulted in some degree of misclassification. However, TOF-MRA is currently the most widely used conventional tool in real-world clinical practice, and we believe that classification and analysis based on it will be of practical benefit. Future studies incorporating advanced vessel wall imaging techniques may help validate and refine our findings."

CFD Simulation Limitations

We agree that our CFD analysis employs several simplifications that do not fully capture the complexity of cerebral hemodynamics. As our CFD model assumes laminar flow rather than turbulent flow due to bending of distal ICA, and generalization was done in patient-specific factors such as endothelial function, pulsatility index parameters, along with number and size of perforators—too minute to measure, our CFD analysis remains a conceptual study.

We have expanded our discussion on CFD limitations:

" Our CFD simulations were based on idealized models using average measurements and simplified assumptions, such as steady-state flow and rigid arterial walls, which do not fully reflect the complex, dynamic nature of cerebral blood flow. These models did not incorporate individual anatomical variations, including the precise angle and number of perforators, variations in vessel diameter, or potential focal irregularities in the M1 segment. Furthermore, standardized parameters may overlook inter-individual differences in collateral flow patterns and cerebrovascular reactivity, both of which could significantly influence local hemodynamics. These limitations necessitate cautious interpretation of our findings and underscore the importance of future studies employing patient-specific CFD modeling with pulsatile flow, arterial wall elasticity, and high-resolution imaging to improve physiological accuracy and clinical relevance. In subsequent studies, we intend to employ 3D printing and particle image velocimetry."

ROC Analysis and Cut-off Value

As suggested, we have performed ROC analysis and added the following to the Results section:

" To assess the diagnostic utility of the proximal/distal M1 diameter ratio in distinguishing LD from BAD, we performed receiver operating characteristic (ROC) curve analysis. The proximal/distal M1 diameter ratio demonstrated poor discriminative ability with an area under the curve (AUC) of 0.665 (95% CI 0.565-0.764, p=0.002). The optimal cut-off value we used was 112.5%, yielding both sensitivity and specificity of 62.3% for identifying LD.

We have also added a new figure (Figure 4) showing the ROC curve and included brief discussion of the clinical implications of this cut-off value in the Discussion section:

"Finally, while our ROC curve analysis shows poor discriminative ability with an AUC of 0.665, and moderate sensitivity and specificity at our cut-off value of 112.5% for the proximal/distal M1 diameter ratio, we can suggest it is not yet an adequate diagnostic method for distinguishing between LD and BAD alone (Fig 4). It should be considered as one component within a comprehensive diagnostic assessment rather than a standalone criterion. Future studies should investigate whether combining this geometric parameter with other clinical and radiological features could improve diagnostic accuracy."

We believe these additions have substantially strengthened the manuscript and addressed all points raised by Reviewer #2. We are grateful for their constructive feedback that has helped enhance the quality and clinical relevance of our study.

2. Figure Presentation

- In Figure 1, some label texts seem to lack sufficient contrast with the background, which may reduce readability. Adjusting text color or weight could enhance visual clarity.

- Figure 2 appears to have relatively low resolution. A higher-quality version would likely improve overall image presentation.

- In Figure 3, several text labels look slightly distorted or unclear. Improving the sharpness and clarity of these labels may enhance the figure's effectiveness.

In response to the reviewers’ comments, we have made efforts to enhance the quality of the images.

Additionally, as the manuscript has become more extensive with the inclusion of new content, we have chosen to narrow the focus in order to better convey our main message. Consequently, the analysis of the relationship between MCA tortuosity and LD has been deferred to a future report, and Figure 2 and the related content have been excluded from t

Attachments
Attachment
Submitted filename: Response to Reviewers.doc.docx
Decision Letter - Atakan Orscelik, Editor

Proximal and distal middle cerebral artery diameter ratio and lenticulostriate artery infarction

PONE-D-25-05856R1

Dear Dr. Kim,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Atakan Orscelik

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: thank you for adressing my comments, i have no further comments and I congratulate authors for their hardwork!

Reviewer #2: The revised manuscript exhibits enhanced clarity, methodological rigor, and transparency. Inter‑observer reliability with ICC values is now included; the discussion accurately addresses TOF‑MRA’s limitations and the potential of vessel‑wall imaging; key CFD assumptions are explicitly stated; and ROC analysis with quantitative metrics has been incorporated. The authors have also refined the manuscript’s focus by deferring the MCA tortuosity analysis, which appropriately streamlines this version. These updates meaningfully strengthen the study. The authors’ scholarly diligence and respectful engagement throughout the revision process are commendable.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Il Kwon

**********

Formally Accepted
Acceptance Letter - Atakan Orscelik, Editor

PONE-D-25-05856R1

PLOS ONE

Dear Dr. Kim,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Atakan Orscelik

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .